The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Gujarat Kidney and Super Speciality Ltd

Gujarat Kidney and Super Speciality Ltd

BSE 544666 · NSE GKSL · ISIN INE0V0W01025 · Group B · Active

Healthcare › Healthcare › Healthcare Services › Hospital

₹160.85

+4.52%

BSE close, 28 August 2026

Market cap

₹1,268.19 cr

7.9 cr shares · Micro cap

Free float

₹353.87 cr

as published

P/E · P/B

157.7× · —

EPS ₹1.02 · BV —

FY25-26 rev / PAT

40.10 / 9.90

₹ cr, as filed

Filings, window

22

6 selected · 27%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹98.25 52-WK HIGH ₹163.50 ₹160.85 96% of range
Against 52-week high-1.6%
Against 52-week low+63.7%
Day change+4.52%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹1.02
Price / earnings157.70×
Price / book—
Book value — derived, price ÷ P/B—
Return on equity—
Operating margin39.39%
Net margin22.04%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 9.24 2.04 0.26 39.39% 22.04%
Mar-26 · Q 9.24 1.37 0.22 21.92% 14.80%
FY25-26 40.10 9.90 1.59 41.49% 24.69%

Quarter on quarter

Revenue, quarter on quarter
+0.0%
Net profit, quarter on quarter
+48.9%
Operating margin, quarter on quarter
+1,747 bps

Disclosure profile 22 filings in the window

0 median 17.0 p75 · 25 sector max 52 22 68th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

22 filings · 6 selected · busiest 2026-08-14 and 2026-08-24

Filing rhythm · the twelve most recent

2026-08-242026-10-05

SelectedProcedural

Filings

22 in the window · 8 earlier on record

  1. 5 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate under Reg 74 (5) of SEBI (DP) Regulations

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  2. 29 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Scrutinizer Report for the AGM held on 28.09.2026

    AGM/EGM / AGM View filing →

  3. 28 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Outcome of 7th AGM

    AGM/EGM / AGM View filing →

  4. 4 September 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper Publication

    Company Update / Newspaper Publication View filing →

  5. 3 September 2026 ·

    AGM / EGM

    AGM To Be Held On 28-09-2026

    Notice of AGM to be conducted on 28-09-2026

    AGM/EGM / AGM View filing →

  6. 3 September 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Revised Annual Report

    Others / Reg. 34 (1) Annual Report View filing →

  7. 3 September 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Annual Report for the Financial year 2025-26

    Others / Reg. 34 (1) Annual Report View filing →

  8. 1 September 2026 ·

    General

    Intimation Of Pre-Advertisement-Notice Of Annual General Meeting Of The Company

    Intimation of Pre-Advertisement- Notice of Annual General Meeting of the Company

    Company Update / General View filing →

  9. 27 August 2026 ·

    Investor Presentation

    Investor Presentation

    Intimation of Analyst/ Investor meet on August 31, 2026 on GIA healthcare Day.

    Company Update / Investor Presentation View filing →

  10. 24 August 2026 ·

    General

    Outcome Of Board Meeting

    Outcome of Board Meeting for Appointment of Additional Director and taking note of resolution approved through Postal Ballot.

    Company Update / General View filing →

  11. 24 August 2026 ·

    Change in Management

    Change in Management

    Appointment of Additional Director, subject to confirmation by Shareholders at ensuing Annual General meeting.

    Company Update / Change in Management View filing →

  12. 24 August 2026 ·

    Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Held On 24-08-2026

    Outcome of Board meeting held on 24-08-2026 for appointment of Additional Director, subject to approval of shareholders at ensuing Annual General Meeting and taking note of approval of ....

    Others / Outcome without intimation View filing →

  13. 24 August 2026 ·

    Postal Ballot

    Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    Outcome of Postal ballot

    AGM/EGM / Postal Ballot View filing →

  14. 24 August 2026 ·

    Postal Ballot

    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

    Postal ballot Result declared.

    AGM/EGM / Postal Ballot View filing →

  15. 14 August 2026 ·

    Monitoring Agency

    Monitoring Agency Report

    Monitoring Agency Report June 2026

    Company Update / Monitoring Agency Report View filing →

  16. 14 August 2026 ·

    Other Update

    Statement Of Deviation & Variation As On June 30, 2026

    Statement of Deviation & Variation as on June 30, 2026

    Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →

  17. 14 August 2026 ·

    Results

    Financial Results For Quarter Ended June 2026

    Financial Results for Quarter ended June 2026

    Result / Financial Results View filing →

  18. 14 August 2026 ·

    Change in Management

    Change in Management

    Change in Category of Mr Paresh Dhoti from Additional Director - Non Executive- Non Independent to Additional Director- Non Executive-Independent (appointment shall be subject to approval ....

    Company Update / Change in Management View filing →

  19. 14 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting

    Outcome of Board meeting for consideration of Unaudited financial results and other matters.

    Board Meeting / Outcome of Board Meeting View filing →

  20. 6 August 2026 ·

    Board Meeting

    Board Meeting Intimation for Approval Of Quarterly Results And Other Businesses

    Gujarat Kidney And Super Speciality Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Unaudited ....

    Board Meeting / Board Meeting View filing →

  21. 23 July 2026 ·

    Postal Ballot

    Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    Newspaper publication of Notice of Postal Ballot

    AGM/EGM / Postal Ballot View filing →

  22. 21 July 2026 ·

    Change in Management

    Change in Management

    Clarification in relation to appointment of Additional Director

    Company Update / Change in Management View filing →

RSS feed for Gujarat Kidney and Super Speciality Ltd · the 50 most recent filings